Tumor Necrosis Factor Receptor Superfamily Member 21 (TNFRSF21) is a type I transmembrane receptor that includes four extracellular cysteine-rich motifs and a cytoplasmic death domain. DR6 is highly expressed in heart; brain; placenta; pancreas; lymph node; thymus and prostate. DR6 may activate NF-kappa-B and JNK to promote apoptosis and T-cell differentiation. In addition; DR6 binds with N-APP; which is released by the deprivation of Trophic-factor. It triggers caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6). DR6 is also expressed on the tumor cell lines and can be induced by TNF-α.

Codice: PKSH033441_50μg | Marca: Elabscience | Confezionamento: 50μg

Specie: Human
Dettagli prodotto
  • Codice: PKSH033441_50μg
  • Marca: Elabscience
  • Specie target: Human
  • Host: HEK293 Cells
  • Confezionamento: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH 7.4.<br/>Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.<br/>Please refer to the specific buffer information in the printed manual.
  • Link: Apri link
  • Stoccaggio: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
  • Simbolo target: DR6;TNFRSF21
  • Ig target: CD358;DR6;Death Receptor 6;TNFRSF21;Tumor Necrosis Factor Receptor Superfamily Member 21
  • Area di ricerca: Cell biology